Jennifer Koh

Represented ResMed Inc. in seven IPRs involving continuous positive airway pressure (CPAP) machines. Successfully obtained final written decisions finding all 140 challenged claims unpatentable.
Represented a major pharmaceutical company in Hatch-Waxman litigation involving its branded epinephrine product. The District Court found that the company''s patents were infringed and not invalid, and the competitor product was enjoined until patent expiration.
Represented a major pharmaceutical company in Hatch-Waxman litigation regarding its patented nasal spray. The parties entered consent judgments that the company''s patents-in-suit were valid, enforceable and infringed.
Represented a major pharmaceutical company in developing multi-pronged patent, trade secret and FDA regulatory strategy to protect company''s flagship injectable drug product against multiple competitors.
Represented a medical device company defending against patent infringement allegations; after failing to obtain an injunction, the patentee agreed to dismiss the lawsuit in its entirety.

Jennifer KohJenniferKoh